Drug Discovery & Development
Discovery of first steps in drug resistance process reveals new targets for antibiotics
Scientists have revealed the initial mechanisms that give rise to drug-resistant Escherichia coli, pointing to potential targets for antibiotics that remain effective as bacteria mutate. Read More
Wyss Institute, Boston Children’s Hospital, Northpond Labs to develop next-gen platform for compound screening
The Wyss Institute for Biologically Inspired Engineering at Harvard University said on Tuesday that it has entered into an agreement with Boston Children’s Hospital and Northpond Labs involving the development of an in vitro high-throughput platform that can identify compounds that bind target proteins with relevance to diseases. Read More
New insights into an old drug: Aspirin
Recent discoveries about how aspirin works to reduce inflammation could lead to alternative medications with fewer side effects. The National Institutes of Health (NIH)-funded research was presented on Tuesday at the annual meeting of the American Society for Biochemistry and Molecular Biology, held March 25-28 in Seattle. Read More
Thermo Fisher Scientific opens cell therapy facility at University of California, San Francisco
Thermo Fisher Scientific and the University of California, San Francisco (UCSF) said Monday that they will develop cell therapies for difficult-to-treat conditions, including cancers, rare diseases, and other illnesses. Read More
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
An analysis of 400 pancreatic cancer tumor samples has linked a protein that controls RNA processing to the formation of metastases, suggesting that it may be possible to delay the spread of the cancer. Read More
Conferences
Science Briefs
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter